|
审核状态: Project audit state: |
通过审核 Successful |
|
注册号: Registration number: |
ChiCTR2400090636 |
|
最近更新日期: Date of Last Refreshed on: |
2024-10-10 14:48:11 |
|
注册时间: Date of Registration: |
2024-10-10 00:00:00 |
|
注册号状态: |
预注册 |
|
Registration Status: |
Prospective registration |
|
注册题目: |
不同关节疾病中关节液pH值的分析研究 |
|
Public title: |
Analysis of the pH value of synovial fluid in different joint diseases |
|
注册题目简写: |
|
|
English Acronym: |
|
|
研究课题的正式科学名称: |
不同关节疾病中关节液pH值的分析研究 |
|
Scientific title: |
Analysis of the pH value of synovial fluid in different joint diseases |
|
研究课题代号(代码): Study subject ID: |
|
|
在二级注册机构或其它机构的注册号: The registration number of the Partner Registry or other register: |
|
申请注册联系人: |
穆文博 |
研究负责人: |
曹力 |
|
Applicant: |
Wenbo Mu |
Study leader: |
Li Cao |
|
申请注册联系人电话: Applicant telephone: |
+86 186 9913 8964 |
研究负责人电话: Study leader's telephone: |
+86 139 0991 5960 |
|
申请注册联系人传真 : Applicant Fax: |
研究负责人传真: Study leader's fax: |
||
|
申请注册联系人电子邮件: Applicant E-mail: |
muwenbo8964@163.com |
研究负责人电子邮件: Study leader's E-mail: |
xjbone@163.com |
|
申请单位网址(自愿提供): Applicant website(voluntary supply): |
研究负责人网址(自愿提供): Study leader's website(voluntary supply): |
||
|
申请注册联系人通讯地址: |
新疆维吾尔自治区乌鲁木齐市鲤鱼山南路137号 |
研究负责人通讯地址: |
新疆维吾尔自治区乌鲁木齐市鲤鱼山南路137号 |
|
Applicant address: |
137 Liyushan Road South, Xinshi District, Urumqi, Xinjiang Uygur Autonomous Region |
Study leader's address: |
137 Liyushan Road South, Xinshi District, Urumqi, Xinjiang Uygur Autonomous Region |
|
申请注册联系人邮政编码: Applicant postcode: |
研究负责人邮政编码: Study leader's postcode: |
||
|
申请人所在单位: |
新疆医科大学第一附属医院 |
||
|
Applicant's institution: |
The First Affliated Hospital of Xinjiang Medical University |
||
|
研究负责人所在单位: |
新疆医科大学第一附属医院 |
||
|
Affiliation of the Leader: |
The First Affliated Hospital of Xinjiang Medical University |
||
|
是否获伦理委员会批准: |
是/Yes |
||
|
Approved by ethic committee: |
Yes |
||
|
伦理委员会批件文号: Approved No. of ethic committee: |
K202409-09 |
伦理委员会批件附件: Approved file of Ethical Committee: |
查看附件View |
|
批准本研究的伦理委员会名称: |
新疆医科大学第一附属医院医学伦理委员会 |
||
|
Name of the ethic committee: |
Medical Ethics Committee of the First Affiliated Hospital of Xinjiang Medical University |
||
|
伦理委员会批准日期: Date of approved by ethic committee: |
2024-09-29 00:00:00 |
||
|
伦理委员会联系人: |
申洁 |
||
|
Contact Name of the ethic committee: |
Shen Jie |
||
|
伦理委员会联系地址: |
新疆维吾尔自治区乌鲁木齐市鲤鱼山南路137号 |
||
|
Contact Address of the ethic committee: |
137 Liyushan Road South, Xinshi District, Urumqi, Xinjiang Uygur Autonomous Region |
||
|
伦理委员会联系人电话: Contact phone of the ethic committee: |
+86 991 436 6135 |
伦理委员会联系人邮箱: Contact email of the ethic committee: |
|
|
研究实施负责(组长)单位: |
新疆医科大学第一附属医院 |
||||||||||||||||||||||
|
Primary sponsor: |
the First Affliated Hospital of Xinjiang Medical University |
||||||||||||||||||||||
|
研究实施负责(组长)单位地址: |
新疆维吾尔自治区乌鲁木齐市鲤鱼山南路137号 |
||||||||||||||||||||||
|
Primary sponsor's address: |
137 Liyushan South Road, Urumqi, Xinjiang Uygur Autonomous Region, China |
||||||||||||||||||||||
|
试验主办单位(项目批准或申办者): Secondary sponsor: |
|
||||||||||||||||||||||
|
经费或物资来源: |
新疆维吾尔自治区科技计划重大专项项目 |
||||||||||||||||||||||
|
Source(s) of funding: |
Major Special Projects of Science and Technology Plan of Xinjiang Uygur Autonomous Region |
||||||||||||||||||||||
|
Target disease: |
Primary Osteoarthritis,Rheumatoid Arthritis,Kashin-Beck Disease,Developmental Dislocation of the Hip,Avascular Necrosis of the Femoral Head,Ankylosing Spondylitis, Periprosthetic joint infection, Aseptic failure after total joint arthroplasty |
||||||||||||||||||||||
|
Target disease code: |
|
||||||||||||||||||||||
|
研究类型: |
诊断试验 |
||||||||||||||||||||||
|
Study type: |
Diagnostic test |
||||||||||||||||||||||
|
研究所处阶段: |
诊断试验新技术临床试验 | ||||||||||||||||||||||
|
Study phase: |
Diagnostic New Technique Clincal Study |
||||||||||||||||||||||
|
研究设计: |
连续入组 |
||||||||||||||||||||||
|
Study design: |
Sequential |
||||||||||||||||||||||
|
研究目的: |
本研究的目的为调查关节假体周围感染患者、关节置换术后无菌性失败患者和因非感染性病因行初次关节置换患者的关节液pH值,明确其保存条件和随时间变化情况,从而得到关节液pH值用于诊断关节假体周围感染的最佳阈值和最适条件。 |
||||||||||||||||||||||
|
Objectives of Study: |
The purpose of this study is to investigate the pH value of joint fluid in patients with PJI, patients with aseptic failure after joint replacement, and patients undergoing primary joint replacement for non-infectious causes, and to determine its storage conditions and changes over time, so as to obtain the optimal threshold and optimal condition of synovial fluid pH value for the diagnosis of PJI. |
||||||||||||||||||||||
|
药物成份或治疗方案详述: |
无 |
||||||||||||||||||||||
|
Description for medicine or protocol of treatment in detail: |
None |
||||||||||||||||||||||
|
纳入标准: |
1.实验组患者的诊断需符合2018MSIS的PJI标准; 2.对照组1患者需确诊为无菌性松动; 3.对照组2患者为因骨关节炎和类风湿性关节炎行初次髋膝关节置换。 |
||||||||||||||||||||||
|
Inclusion criteria |
1. The diagnosis of patients in the experimental group should meet the 2018MSIS PJI criteria; 2. Patients in control group 1 should be diagnosed as aseptic loosening; 3. Patients in control group 2 underwent primary hip and knee arthroplasty due to osteoarthritis and rheumatoid arthritis. |
||||||||||||||||||||||
|
排除标准: |
1.初次关节置换术的原发病为感染性病因; 2.有转移性疾病史(肿瘤)的患者; 3.有吸毒史的患者。 |
||||||||||||||||||||||
|
Exclusion criteria: |
1. The primary disease of primary arthroplasty was infectious; 2. Patients with a history of metastatic disease (cancer); 3. Patients with drug use history. |
||||||||||||||||||||||
|
研究实施时间: Study execute time: |
从 From 2024-10-14 00:00:00至 To 2025-10-13 00:00:00 |
征募观察对象时间: Recruiting time: |
从From 2024-10-14 00:00:00 至 To 2025-10-13 00:00:00 |
|
诊断试验: Diagnostic Tests: |
|
||||||||||||||||||||||||||||
|
研究实施地点: Countries of recruitment and research settings: |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
测量指标: Outcomes: |
|
|
采集人体标本:
Collecting sample(s)
|
|
|
征募研究对象情况: Recruiting status: |
尚未开始 Not yet recruiting |
年龄范围: Participant age: |
|
||||||
|
性别: |
男女均可 |
Gender: |
Both |
||||||
|
随机方法(请说明由何人用什么方法产生随机序列): |
非随机对照试验 |
||||||||
|
Randomization Procedure (please state who generates the random number sequence and by what method): |
Non randomization. |
||||||||
|
是否公开试验完成后的统计结果: Calculated Results after the Study Completed public access: |
公开/Public |
|
盲法: |
无 |
|
Blinding: |
None |
|
试验完成后的统计结果(上传文件): |
|
|
Calculated Results after
|
|
|
是否共享原始数据: IPD sharing |
Yes |
|
共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址): |
临床试验公共管理平台 IPD(http://www.medresman.org.cn)。论文发表后半年,以上传原始数据形式 |
|
The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url): |
ResMan IPD (http://www.medresman.org.cn) . Half a year after the paper was published |
|
数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC: |
一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC) |
|
Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture: |
One is Case Record Form, CRF), the other is Electronic Data Capture, EDC). |
|
数据与安全监察委员会: Data and Safety Monitoring Committee: |
有/Yes |